Lunai Bioworks raises $20M to acquire CNS delivery technology
Lunai Bioworks Inc. (NASDAQ: LNAI) completed a $20 million preferred equity issuance to acquire intellectual property assets from two counterparties ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
